Cargando…
Intraperitoneal BromAc(®) Does Not Interfere with the Healing of Colon Anastomosis
SIMPLE SUMMARY: The drug BromAc(®) has been used in the treatment of pseudomyxoma peritonei, a rare peritoneal cancer. Often, patients with pseudomyxoma peritonei require colon resection with reconnection. Hence, we investigated whether BromAc(®) affects the healing of bowel wounds using a rat model...
Autores principales: | Mekkawy, Ahmed H., Breakeit, Mohammad, Pillai, Krishna, Badar, Samina, Akhter, Javed, Valle, Sarah J., Morris, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340507/ https://www.ncbi.nlm.nih.gov/pubmed/37444430 http://dx.doi.org/10.3390/cancers15133321 |
Ejemplares similares
-
The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study
por: Ke, Kevin, et al.
Publicado: (2021) -
The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2
por: Akhter, Javed, et al.
Publicado: (2021) -
Effect of Nebulized BromAc on Rheology of Artificial Sputum: Relevance to Muco-Obstructive Respiratory Diseases
por: Pillai, Krishna, et al.
Publicado: (2023) -
Novel Use of Bromelain and Acetylcysteine (BromAc®) for Pleural Involvement in Pseudomyxoma Peritonei
por: Lam, Anthony R., et al.
Publicado: (2021) -
Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19
por: Coelho dos Reis, Jordana Grazziela A., et al.
Publicado: (2022)